What does COBEA PHARMA do?

COBEA PHARMA is a pharmacy in Villers-la-Ville. Private Limited, started on 18 December 2001, 1 establishment.

What is the address of COBEA PHARMA?

The registered office of COBEA PHARMA is located at Rue de Priesmont 46, 1495 Villers-la-Ville.

Is COBEA PHARMA still active?

Yes. According to the CBE (31 October 2026) COBEA PHARMA is active, legal situation “Normale toestand”, started on 18 December 2001.

Is COBEA PHARMA registered on Peppol?

Yes, COBEA PHARMA is registered on the Peppol network with ID 0208:0476340670.

What is the enterprise number of COBEA PHARMA?

The enterprise number of COBEA PHARMA is BE0476340670.

When was COBEA PHARMA founded?

COBEA PHARMA was founded on 18 December 2001.

Who are the directors of COBEA PHARMA?

According to the 2026 annual accounts, the directors of COBEA PHARMA are: Chatho Immo SRL.

Is COBEA PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 December 2001; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did COBEA PHARMA make in 2026?

COBEA PHARMA posted a profit after taxes of € 9,378 in financial year 2026.

What is the revenue of COBEA PHARMA?

As a small company, COBEA PHARMA is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 144,021.

How much does an employee at COBEA PHARMA earn?

The average wage cost per full-time employee at COBEA PHARMA was € 61,700 in 2026: staff costs of € 123,364 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does COBEA PHARMA have?

According to the 2026 annual accounts, COBEA PHARMA has 2 full-time equivalents (FTE).

Does COBEA PHARMA have a website?

Yes, COBEA PHARMA has a website at cobeapharma.be.

COBEA PHARMA (Private Limited) - Villers-la-Ville

Dossier COBEA PHARMA, printed on 31 October 2026 from databakkes.be/en/0476340670/cobea-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

COBEA PHARMA from Villers-la-Ville, company number BE0476340670, closed financial year 2026 with a result of € 9,378 after tax. For that financial year COBEA PHARMA recorded a gross margin of € 144,021 and equity of € 146,454. Compared with financial year 2025, the result moved from € 3,632 to € 9,378. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.

What it is worth Growing

€ 146,454

▲ 7% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,378

▲ 158% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 141,453

▲ 12% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 127,854.

People and assets in 2026

Full-time equivalents

▲ 0.1 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 123,364

▲ 9% vs 2025

€ 61,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 233

▼ 58% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 187,748

▼ 5% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,271

▲ 17% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 166,610 Gross margin 2023: € 166,610 First fiscal year in the series	€ 155,640 Gross margin 2024: € 155,640 ▼ 7% vs 2023 (€ 166,610) Unfavourable step	€ 128,778 Gross margin 2025: € 128,778 ▼ 17% vs 2024 (€ 155,640) Unfavourable step	€ 144,021 Gross margin 2026: € 144,021 ▲ 12% vs 2025 (€ 128,778) Favourable step	▲ 12%
Profit after taxes	€ 26,857 Profit after taxes 2023: € 26,857 First fiscal year in the series	€ 19,274 Profit after taxes 2024: € 19,274 ▼ 28% vs 2023 (€ 26,857) Unfavourable step	€ 3,632 Profit after taxes 2025: € 3,632 ▼ 81% vs 2024 (€ 19,274) Unfavourable step	€ 9,378 Profit after taxes 2026: € 9,378 ▲ 158% vs 2025 (€ 3,632) Favourable step	▲ 158%
Equity	€ 134,169 Equity 2023: € 134,169 First fiscal year in the series	€ 133,444 Equity 2024: € 133,444 ▼ 1% vs 2023 (€ 134,169) Unfavourable step	€ 137,076 Equity 2025: € 137,076 ▲ 3% vs 2024 (€ 133,444) Favourable step	€ 146,454 Equity 2026: € 146,454 ▲ 7% vs 2025 (€ 137,076) Favourable step	▲ 7%
Total debts	€ 282,113 Total debts 2023: € 282,113 First fiscal year in the series	€ 244,234 Total debts 2024: € 244,234 ▼ 13% vs 2023 (€ 282,113) Favourable step	€ 219,651 Total debts 2025: € 219,651 ▼ 10% vs 2024 (€ 244,234) Favourable step	€ 216,369 Total debts 2026: € 216,369 ▼ 1% vs 2025 (€ 219,651) Favourable step	▼ 1%
Cash	€ 187,856 Cash 2023: € 187,856 First fiscal year in the series	€ 144,876 Cash 2024: € 144,876 ▼ 23% vs 2023 (€ 187,856) Unfavourable step	€ 126,523 Cash 2025: € 126,523 ▼ 13% vs 2024 (€ 144,876) Unfavourable step	€ 141,453 Cash 2026: € 141,453 ▲ 12% vs 2025 (€ 126,523) Favourable step	▲ 12%
Retained profit	€ 115,569 Retained profit 2023: € 115,569 First fiscal year in the series	€ 114,844 Retained profit 2024: € 114,844 ▼ 1% vs 2023 (€ 115,569) Unfavourable step	€ 118,476 Retained profit 2025: € 118,476 ▲ 3% vs 2024 (€ 114,844) Favourable step	€ 127,854 Retained profit 2026: € 127,854 ▲ 8% vs 2025 (€ 118,476) Favourable step	▲ 8%
Dividend	€ 30,000 Dividend 2023: € 30,000 First fiscal year in the series	€ 20,000 Dividend 2024: € 20,000 ▼ 33% vs 2023 (€ 30,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 20,000) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 33,607 Bank debt 2023: € 33,607 First fiscal year in the series	€ 9,529 Bank debt 2024: € 9,529 ▼ 72% vs 2023 (€ 33,607) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 9,529) Favourable step	€ 0 Bank debt 2026: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 416,283 Balance sheet total 2023: € 416,283 First fiscal year in the series	€ 377,678 Balance sheet total 2024: € 377,678 ▼ 9% vs 2023 (€ 416,283) Unchanged	€ 356,727 Balance sheet total 2025: € 356,727 ▼ 6% vs 2024 (€ 377,678) Unchanged	€ 362,823 Balance sheet total 2026: € 362,823 ▲ 2% vs 2025 (€ 356,727) Unchanged	▲ 2%
Employees (FTE)	1.9 Employees (FTE) 2023: 1.9 First fiscal year in the series	1.9 Employees (FTE) 2024: 1.9 Unchanged (1.9) Unchanged	1.9 Employees (FTE) 2025: 1.9 Unchanged (1.9) Unchanged	2 Employees (FTE) 2026: 2 ▲ 0.1 vs 2025 (1.9) Unchanged	▲ 0.1

Key figures of COBEA PHARMA, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to COBEA PHARMA?

What happened at COBEA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 24, 2026 New annual accounts for financial year 2026: profit of € 9,378 (▲ 158% vs 2025). Source: NBB ↗
Feb 28, 2002 New establishment in Villers-la-Ville. KBO
Dec 18, 2001 Start of the company according to the CBE. KBO

In short

From € 26,857 profit in 2023 to € 9,378 profit in 2026.

Paid € 23,901 in corporate taxes since 2023.

Best year ever: 2023, with € 26,857 profit.

On average € 72,000 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

CHATHO IMMO 100%

The stake of CHATHO IMMO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

COBEA PHARMA

Behind COBEA PHARMA is Chatho Immo SRL. The shares are held by CHATHO IMMO (100%).

Directors

According to the 2026 annual accounts

Chatho Immo SRL

Director · represented by Valérie Poot-Baudier

Shareholders

CHATHO IMMO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Priesmont 46

1495 Villers-la-Ville

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

CHATHO IMMO same network

€ 118,516 gross margin · 2026

GROUPE COBEA

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS cobeapharma.be

Technologies

BootstrapFont AwesomeGoogle FontsJoomlaPHPjQuery

Hosting & Email

Email provider

OVH Mail

Hosting

OVH, FR

DNS

OVH DNS

Website info

HTTPS Ja

Indexable pages 12

Languages FR

Features

Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0476.340.670

VAT number

BE 0476.340.670

Registered office

Rue de Priesmont 46, 1495 Villers-la-Ville

Names & denominations

COBEA PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 December 2001

Peppol

Active · Active since 18 Dec 2025

Contact

cobeapharma.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

COBEA PHARMA

Financials

What happened to COBEA PHARMA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions